Global Plasma-derived Therapies Market Growth (Status and Outlook) 2022-2028
- LP 4895358
- 89 Pages
- March 2022
- Automotive and Transportation
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma-derived Therapies market by product type, application, key players and key regions and countries.
Segmentation by product type:
Albumin
Immunoglobulin
Factor VIII
Others
Segmentation by Application:
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma-derived Therapies Market Size 2022-2028
2.1.2 Plasma-derived Therapies Market Size CAGR by Region
2.2 Plasma-derived Therapies Segment by Type
2.2.1 Albumin
2.2.2 Immunoglobulin
2.2.3 Factor VIII
2.2.4 Others
2.3 Plasma-derived Therapies Market Size by Type
2.3.1 Global Plasma-derived Therapies Market Size Market Share by Type (2022-2028)
2.3.2 Global Plasma-derived Therapies Market Size Growth Rate by Type (2022-2028)
2.4 Plasma-derived Therapies Segment by Application
2.4.1 Hemophilia
2.4.2 Primary Immunodeficiencies (PIDs)
2.4.3 Idiopathic Thrombocytopenic Purpura (ITP)
2.4.4 COVID-19
2.4.5 Others
2.5 Plasma-derived Therapies Market Size by Application
2.5.1 Global Plasma-derived Therapies Market Size Market Share by Application (2022-2028)
2.5.2 Global Plasma-derived Therapies Market Size Growth Rate by Application (2022-2028)
3 Plasma-derived Therapies Key Players
3.1 Date of Key Players Enter into Plasma-derived Therapies
3.2 Key Players Plasma-derived Therapies Product Offered
3.3 Key Players Plasma-derived Therapies Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Plasma-derived Therapies Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Plasma-derived Therapies by Regions
4.1 Plasma-derived Therapies Market Size by Regions (2022-2028)
4.2 United States Plasma-derived Therapies Market Size Growth (2022-2028)
4.3 China Plasma-derived Therapies Market Size Growth (2022-2028)
4.4 Europe Plasma-derived Therapies Market Size Growth (2022-2028)
4.5 Rest of World Plasma-derived Therapies Market Size Growth (2022-2028)
5 United States
5.1 United States Plasma-derived Therapies Market Size by Type (2022-2028)
5.2 United States Plasma-derived Therapies Market Size by Application (2022-2028)
6 China
6.1 China Plasma-derived Therapies Market Size by Type (2022-2028)
6.2 China Plasma-derived Therapies Market Size by Application (2022-2028)
7 Europe
7.1 Europe Plasma-derived Therapies Market Size by Type (2022-2028)
7.2 Europe Plasma-derived Therapies Market Size by Application (2022-2028)
8 Rest of World
8.1 Rest of World Plasma-derived Therapies Market Size by Type (2022-2028)
8.2 Rest of World Plasma-derived Therapies Market Size by Application (2022-2028)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Plasma-derived Therapies
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 CSL Behring LLC
11.1.1 CSL Behring LLC Company Details
11.1.2 CSL Behring LLC Plasma-derived Therapies Product Offered
11.1.3 CSL Behring LLC Plasma-derived Therapies Market Size (2022 VS 2027)
11.1.4 CSL Behring LLC Main Business Overview
11.1.5 CSL Behring LLC News
11.2 Shire
11.2.1 Shire Company Details
11.2.2 Shire Plasma-derived Therapies Product Offered
11.2.3 Shire Plasma-derived Therapies Market Size (2022 VS 2027)
11.2.4 Shire Main Business Overview
11.2.5 Shire News
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Plasma-derived Therapies Product Offered
11.3.3 Bayer Plasma-derived Therapies Market Size (2022 VS 2027)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer News
11.4 Kedrion
11.4.1 Kedrion Company Details
11.4.2 Kedrion Plasma-derived Therapies Product Offered
11.4.3 Kedrion Plasma-derived Therapies Market Size (2022 VS 2027)
11.4.4 Kedrion Main Business Overview
11.4.5 Kedrion News
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Plasma-derived Therapies Product Offered
11.5.3 Takeda Plasma-derived Therapies Market Size (2022 VS 2027)
11.5.4 Takeda Main Business Overview
11.5.5 Takeda News
11.6 Biotest
11.6.1 Biotest Company Details
11.6.2 Biotest Plasma-derived Therapies Product Offered
11.6.3 Biotest Plasma-derived Therapies Market Size (2022 VS 2027)
11.6.4 Biotest Main Business Overview
11.6.5 Biotest News
11.7 Octaparma
11.7.1 Octaparma Company Details
11.7.2 Octaparma Plasma-derived Therapies Product Offered
11.7.3 Octaparma Plasma-derived Therapies Market Size (2022 VS 2027)
11.7.4 Octaparma Main Business Overview
11.7.5 Octaparma News
11.8 Bio Products Laboratory (BPL)
11.8.1 Bio Products Laboratory (BPL) Company Details
11.8.2 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Offered
11.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Market Size (2022 VS 2027)
11.8.4 Bio Products Laboratory (BPL) Main Business Overview
11.8.5 Bio Products Laboratory (BPL) News
11.9 LFB
11.9.1 LFB Company Details
11.9.2 LFB Plasma-derived Therapies Product Offered
11.9.3 LFB Plasma-derived Therapies Market Size (2022 VS 2027)
11.9.4 LFB Main Business Overview
11.9.5 LFB News
11.10 Grifols
11.10.1 Grifols Company Details
11.10.2 Grifols Plasma-derived Therapies Product Offered
11.10.3 Grifols Plasma-derived Therapies Market Size (2022 VS 2027)
11.10.4 Grifols Main Business Overview
11.10.5 Grifols News
12 Research Findings and Conclusion
Table 1. Plasma-derived Therapies Market Size CAGR by Region (2022-2028) ($ Millions)
Table 2. Major Players of Albumin
Table 3. Major Players of Immunoglobulin
Table 4. Major Players of Factor VIII
Table 5. Major Players of Others
Table 6. Global Plasma-derived Therapies Market Size by Type (2022-2028) ($ Millions)
Table 7. Global Plasma-derived Therapies Market Size Market Share by Type (2022-2028)
Table 8. Global Plasma-derived Therapies Market Size by Application (2022-2028) ($ Millions)
Table 9. Global Plasma-derived Therapies Market Size Market Share by Application (2022-2028)
Table 10. Date of Global Key Players Enter into Plasma-derived Therapies Market
Table 11. Global Key Players Plasma-derived Therapies Product Offered
Table 12. Key Players Plasma-derived Therapies Funding/Investment ($ Millions)
Table 13. Funding/Investment by Regions
Table 14. Funding/Investment by End Industry
Table 15. Key Players Plasma-derived Therapies Valuation & Market Capitalization ($ Millions)
Table 16. Key Players Mergers & Acquisitions, Expansion Plans
Table 17. Plasma-derived Therapies New Product/Technology Launches
Table 18. Plasma-derived Therapies Industry Partnerships, Agreements, and Collaborations
Table 19. Plasma-derived Therapies Industry Mergers and Acquisitions
Table 20. Global Plasma-derived Therapies Market Size by Regions 2022-2028 ($ Millions)
Table 21. Global Plasma-derived Therapies Market Size Market Share by Regions 2022-2028
Table 22. United States Plasma-derived Therapies Market Size by Type (2022-2028) ($ Millions)
Table 23. United States Plasma-derived Therapies Market Size Market Share by Type (2022-2028)
Table 24. United States Plasma-derived Therapies Market Size by Application (2022-2028) ($ Millions)
Table 25. United States Plasma-derived Therapies Market Size Market Share by Application (2022-2028)
Table 26. China Plasma-derived Therapies Market Size by Type (2022-2028) ($ Millions)
Table 27. China Plasma-derived Therapies Market Size Market Share by Type (2022-2028)
Table 28. China Plasma-derived Therapies Market Size by Application (2022-2028) ($ Millions)
Table 29. China Plasma-derived Therapies Market Size Market Share by Application (2022-2028)
Table 30. Europe Plasma-derived Therapies Market Size by Type (2022-2028) ($ Millions)
Table 31. Europe Plasma-derived Therapies Market Size Market Share by Type (2022-2028)
Table 32. Europe Plasma-derived Therapies Market Size by Application (2022-2028) ($ Millions)
Table 33. Europe Plasma-derived Therapies Market Size Market Share by Application (2022-2028)
Table 34. Rest of World Plasma-derived Therapies Market Size by Type (2022-2028) ($ Millions)
Table 35. Rest of World Plasma-derived Therapies Market Size Market Share by Type (2022-2028)
Table 36. Rest of World Plasma-derived Therapies Market Size by Application (2022-2028) ($ Millions)
Table 37. Rest of World Plasma-derived Therapies Market Size Market Share by Application (2022-2028)
Table 38. Key Market Drivers & Growth Opportunities of Plasma-derived Therapies
Table 39. Key Market Challenges & Risks of Plasma-derived Therapies
Table 40. Key Industry Trends of Plasma-derived Therapies
Table 41. Company A Company Details
Table 42. Companies Invested by Company A
Table 43. Company A Key Development and Market Layout
Table 44. Company B Company Details
Table 45. Companies Invested by Company B
Table 46. Company B Key Development and Market Layout
Table 47. Company C Company Details
Table 48. Companies Invested by Company C
Table 49. Company C Key Development and Market Layout
Table 50. Company C Company Details
Table 51. Companies Invested by Company C
Table 52. Company C Key Development and Market Layout
Table 53. CSL Behring LLC Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. CSL Behring LLC Plasma-derived Therapies Market Size (2022 VS 2027)
Table 55. Shire Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. Shire Plasma-derived Therapies Market Size (2022 VS 2027)
Table 57. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Bayer Plasma-derived Therapies Market Size (2022 VS 2027)
Table 59. Kedrion Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Kedrion Plasma-derived Therapies Market Size (2022 VS 2027)
Table 61. Takeda Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Takeda Plasma-derived Therapies Market Size (2022 VS 2027)
Table 63. Biotest Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Biotest Plasma-derived Therapies Market Size (2022 VS 2027)
Table 65. Octaparma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. Octaparma Plasma-derived Therapies Market Size (2022 VS 2027)
Table 67. Bio Products Laboratory (BPL) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. Bio Products Laboratory (BPL) Plasma-derived Therapies Market Size (2022 VS 2027)
Table 69. LFB Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. LFB Plasma-derived Therapies Market Size (2022 VS 2027)
Table 71. Grifols Basic Information, Head Office, Major Market Areas and Its Competitors
Table 72. Grifols Plasma-derived Therapies Market Size (2022 VS 2027)
List of Figures
Figure 1. Picture of Plasma-derived Therapies
Figure 2. Plasma-derived Therapies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma-derived Therapies Market Size Growth Rate 2022-2028 ($ Millions)
Figure 7. Plasma-derived Therapies Market Size by Region (2022 & 2027) ($ millions)
Figure 8. Global Plasma-derived Therapies Market Size Market Share by Type (2022-2028)
Figure 9. Global Albumin Market Size Growth Rate
Figure 10. Global Immunoglobulin Market Size Growth Rate
Figure 11. Global Factor VIII Market Size Growth Rate
Figure 12. Global Others Market Size Growth Rate
Figure 13. Plasma-derived Therapies in Hemophilia
Figure 14. Global Plasma-derived Therapies Market: Hemophilia (2022-2028) ($ Millions)
Figure 15. Plasma-derived Therapies in Primary Immunodeficiencies (PIDs)
Figure 16. Global Plasma-derived Therapies Market: Primary Immunodeficiencies (PIDs) (2022-2028) ($ Millions)
Figure 17. Plasma-derived Therapies in Idiopathic Thrombocytopenic Purpura (ITP)
Figure 18. Global Plasma-derived Therapies Market: Idiopathic Thrombocytopenic Purpura (ITP) (2022-2028) ($ Millions)
Figure 19. Plasma-derived Therapies in COVID-19
Figure 20. Global Plasma-derived Therapies Market: COVID-19 (2022-2028) ($ Millions)
Figure 21. Plasma-derived Therapies in Others
Figure 22. Global Plasma-derived Therapies Market: Others (2022-2028) ($ Millions)
Figure 23. Global Plasma-derived Therapies Market Size Market Share by Application (2022-2028)
Figure 24. Global Plasma-derived Therapies Market Size in Hemophilia Growth Rate
Figure 25. Global Plasma-derived Therapies Market Size in Primary Immunodeficiencies (PIDs) Growth Rate
Figure 26. Global Plasma-derived Therapies Market Size in Idiopathic Thrombocytopenic Purpura (ITP) Growth Rate
Figure 27. Global Plasma-derived Therapies Market Size in COVID-19 Growth Rate
Figure 28. Global Plasma-derived Therapies Market Size in Others Growth Rate
Figure 29. Funding/Investment
Figure 30. Global Plasma-derived Therapies Market Size Market Share by Regions 2022-2028
Figure 31. United States Plasma-derived Therapies Market Size 2022-2028 ($ Millions)
Figure 32. China Plasma-derived Therapies Market Size 2022-2028 ($ Millions)
Figure 33. Europe Plasma-derived Therapies Market Size 2022-2028 ($ Millions)
Figure 34. Rest of World Plasma-derived Therapies Market Size 2022-2028 ($ Millions)
Figure 35. United States Plasma-derived Therapies Consumption Market Share by Type in 2027
Figure 36. United States Plasma-derived Therapies Market Size Market Share by Application in 2027
Figure 37. China Plasma-derived Therapies Consumption Market Share by Type in 2027
Figure 38. China Plasma-derived Therapies Market Size Market Share by Application in 2027
Figure 39. Europe Plasma-derived Therapies Consumption Market Share by Type in 2027
Figure 40. Europe Plasma-derived Therapies Market Size Market Share by Application in 2027
Figure 41. Rest of World Plasma-derived Therapies Consumption Market Share by Type in 2027
Figure 42. Rest of World Plasma-derived Therapies Market Size Market Share by Application in 2027
Similar Reports
The project logistics market in India is pegged at INR 200 bn in 2010 and is growing at a CAGR of 20%. Rapid core infrastructure development along with investment planned by the Government of India and private players will drive the project logistics market. The report begins with an introduction to the project logistics market in India, describing the types of cargo being transported and share...
- Publish Date: January 3, 2011
- $950
The luxury car market is expected to witness strong growth with rising number of foreign players planning expansions in the market. Growing number of young entrepreneurs in India inclined to drive luxury cars is brining about healthy demand for such cars. The report provides a brief overview of the automotive market in India, the production of passenger vehicles over years and the segmented share...
- Publish Date: January 5, 2011
- $950
In India, car accessories is a new concept which has gained popularity in recent times with growing usage of high end cars. The market can be divided into interior and exterior car accessories. In the Indian market, interior car accessories are more popular. The growing youth is providing a fillip to the market due to their perceptions and preferences. Although small cars are preferred by Indian c...
- Publish Date: January 28, 2011
- $950
